Stay updated on CP-690,550 Dose Comparison in RA Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.

Latest updates to the CP-690,550 Dose Comparison in RA Clinical Trial page
- Check4 days agoChange DetectedThe study locations list was expanded to include many new sites across the United States (e.g., Arizona, Florida, Illinois, Maryland, Massachusetts, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Washington, West Virginia) and internationally (e.g., Goiás, Paraná, Rio de Janeiro, Rio Grande do Sul, São Paulo, RM, Santiago RM, Santander Department, Santo Domingo Province, Andhra Pradesh, Gujarat, Karnataka, Maharashtra, Kuala Lumpur, Sabah, Sarawak, Selangor, Chihuahua, Baja California, Jalisco, Nuevo León, Cavite, Philippines). The location sections were reorganized to reflect these sites.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check34 days agoChange DetectedMinor editorial updates to the Publications section: added a line noting that PubMed-sourced publications are automatically filled for the study, and updated the revision information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page no longer displays the government funding lapse notice banner that previously informed users about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedNo significant content changes were detected between the two screenshots. The study detail page content appears unchanged, with only minor UI adjustments that do not affect the core information.SummaryDifference0.2%

- Check84 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference1%

- Check91 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.1%

Stay in the know with updates to CP-690,550 Dose Comparison in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.